Related Experiment Video
Updated: Feb 1, 2026

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
Cardiomyocyte-specific deficiency of C/EBPβ aggravates pressure overload-induced heart failure
Jihoon Nah1,2, Eun-Ah Sung1, Peiyong Zhai1
1Department of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
Insights
CCAAT-enhancer-binding protein β (C/EBPβ) in heart cells is crucial for preventing heart failure during pressure overload. Loss of C/EBPβ in cardiomyocytes worsens cardiac dysfunction and fibrosis, highlighting its protective role.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Gene Regulation
Background:
- CCAAT-enhancer-binding protein β (C/EBPβ) is a transcription factor involved in cellular processes.
- C/EBPβ has known roles in the heart, but its cell-type specific functions during cardiac stress are unclear.
Purpose of the Study:
- To investigate the role of endogenous C/EBPβ in cardiomyocytes during pressure overload-induced heart failure.
Main Methods:
- Generated cardiomyocyte-specific Cebpb knockout (Cebpb-cKO) mice.
- Subjected mice to transverse aortic constriction (TAC) to induce pressure overload.
- Assessed cardiac function, hypertrophy, fibrosis, and gene expression.
Main Results:
- C/EBPβ expression decreased in wild-type hearts post-TAC.
- Cebpb-cKO mice exhibited exacerbated systolic dysfunction, hypertrophy, and fibrosis after TAC.
- Loss of C/EBPβ reduced antioxidant gene expression and worsened cardiac function.
Conclusions:
- Endogenous C/EBPβ in cardiomyocytes plays a protective role during pressure overload.
- C/EBPβ exhibits cell-type specific functions in the heart.
- Restoring C/EBPβ in cardiomyocytes improved cardiac function post-TAC.
Aims:
CCAAT/enhancer-binding protein (C/EBP) β is a member of the basic-leucine zipper transcription factor family that regulates cell differentiation, proliferation, cell death and survival, and inflammation. Although C/EBPβ plays both protective and detrimental roles in the heart at baseline and during stress, the cell-type-specific functions of C/EBPβ in the heart are unknown. Here, we investigated the role of endogenous C/EBPβ in cardiomyocytes during pressure overload (PO)-induced heart failure.
Methods And Results:
We found that C/EBPβ expression was reduced in wild-type mouse heart homogenates after 4 weeks of transverse aortic constriction (TAC). To elucidate the role of endogenous C/EBPβ during cardiac stress in vivo, we generated cardiomyocyte-specific Cebpb knockout (Cebpb-cKO) mice. Cebpb-cKO mice were born at a normal Mendelian ratio but displayed slightly decreased cardiac function under baseline conditions, starting at 3 months of age. Notably, in contrast to a previous report using systemic heterozygous Cebpb-knockout mice, which exhibited cardiac protection against TAC, Cebpb-cKO mice showed significantly exacerbated systolic dysfunction, cardiac hypertrophy, and fibrosis after 4 weeks of TAC. Cebpb-cKO mice also exhibited decreased expression of antioxidant genes, including Mnsod and Catalase, both at baseline and under TAC conditions. On the other hand, rescue of the C/EBPβ level in cardiomyocytes using AAV9-cTnT-Cebpb alleviated the left ventricular dysfunction in response to TAC.
Conclusion:
Our findings suggest that C/EBPβ has a cell-type-specific role in the heart and that endogenous C/EBPβ in cardiomyocytes plays a salutary role during PO.
More Related Videos
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management

